Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?
J Endocrinol Invest
; 40(8): 885-887, 2017 08.
Article
in En
| MEDLINE
| ID: mdl-28634704
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Graves Disease
/
Graves Ophthalmopathy
Limits:
Humans
Language:
En
Journal:
J Endocrinol Invest
Year:
2017
Document type:
Article